Vantrexa · NSCLC · Spain · Oncology pharmacist · captured by Rachel Adeyemi on 08 Jan 2026 · reviewed by Dr. Priya Raman on 09 Jan 2026
Verbatim as captured; never edited
Oncology pharmacist at Hospital Clínic Barcelona raised brain-metastasis subgroup data during a scientific exchange. They indicated this influences their current prescribing approach.
Human-approved by Dr. Priya Raman on 09 Jan 2026
Brain-metastasis subgroup data: gap in current materials reported by oncology pharmacist (ES).
helixor-private-llm-2026.05 · generated 08 Jan 2026, 10:00 UTC
AI summary
Brain-metastasis subgroup data raised by oncology pharmacist; suggest routing to Clinical Development.
Source spans used by the model
Oncology pharmacist at Hospital Clínic Barcelona raised brain-metastasis subgroup data during a scientific exchange. They indicated this influences their current prescribing approach.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Efficacy | Efficacy |
| Function | Clinical Development | Clinical Development |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 5 | 20% | 20.0 |
| Strategic alignment | 5 | 20% | 20.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 1 | 10% | 2.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | High 76 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
No further actions; record is archived.
Who reviewed, what action, which function, what decision, what outcome, when closed
07 Jan 2026 · Dr. Noor Abbott, Hospital Clínic Barcelona · MSL Rachel Adeyemi
Insight
Reviewed 09 Jan 2026 by Dr. Priya Raman
Action
Initiative
Decision
Outcome
Closure
Standard response created and approved.